Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

The FDA is in breach of its own guidelines. At the

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155568
(Total Views: 795)
Posted On: 07/15/2020 4:50:04 PM
Posted By: ohm20
Re: lorbas #43096
The FDA is in breach of its own guidelines. At the pre-submission meeting it was established that the FDA wanted safety data from 50 more 700mg patients in the monotherapy trial. When the company achieved that the FDA changed its mind and has now done so once again.

As far as re-submitting the application, not necessarily. That's what the type A meeting will determine. If the FDA still refuses to submit Nader should still insist on filing under protest. By the time of that meeting we will have the leverage of publicity and to not file under protest would be negligent on Nader's part.

Quote:
When discussing the planned submission of these applications at a presubmission meeting, the FDA and the applicant reach agreements regarding the content of a complete application for the
proposed indication(s) as well as agreements, if any, on submission of minor components that may be submitted not later than 30 calendar days after submission of the original application. Unless the applicant and the FDA have agreed at the presubmission meeting to delayed
submission of certain components of the application, the FDA expects applications to be complete at the time of submission. If agreed-upon delayed minor components are not received within 30 calendar days after receipt of the original application, the application will be considered incomplete. Incomplete applications may be refused for filing. A rolling review permitted under fast track designation has similar obligations.



Quote:
Within 30 days of the date of the review division’s RTF notification, the applicant may request in writing an informal conference with the FDA to discuss whether the FDA should file the
application.

In general, the review division will grant an informal conference request if submitted within the 30-day time frame described above. If, after the informal conference, the applicant requests that the review division file the application (with or without amendments to correct the
deficiencies), the review division will file the application over protest pursuant to § 314.101(a)(3), notify the applicant in writing, and review it as filed. The applicant need not resubmit a copy of an application filed over protest. If an NDA is filed over protest, the filing date will be designated as 60 days after the receipt date of the informal conference meeting request. Applications for NME NDAs or original BLAs received between October 1, 2012, through September 30, 2017, that are filed over protest will not be reviewed under the Program. Alternatively, the applicant may amend the NDA and resubmit it, and the review division will make a separate determination whether the resubmitted NDA may be filed.



https://www.fda.gov/media/109758/download


(11)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us